Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 30/09/19961 min de lecture
Prospective Grant of Exclusive License: Therapeutic Polyamines
Traduction automatique locale · Langue originale de la source
Résumé
This notice is in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.8(a)(1)(I) that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive world-wide license to practice the inventions embodied in U.S. Patent No. 5,541,230 and a divisional thereto (U.S. Patent Application No. to be assigned) to S'LIL Pharmaceuticals of Madison, Wisconsin.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →